Journal Watch 18/10/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
top of page
Browse by category
Search
SURMOUNT-3: Tirzepatide shows total mean weight loss of 26.6% from study entry over 84 weeks
Detailed results from the phase 3 SURMOUNT-3 clinical trial evaluating tirzepatide in adults with obesity or overweight with...
Browse by tag
bottom of page